ARK Investment Management Q2 2022 holdings

$16.9 Billion is the total value of ARK Investment Management's 354 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 100.0% .

 Value Shares↓ Weighting
IRCLF ExitIntercure Ltd$0-257
-100.0%
0.00%
PYPD ExitPolyPid Ltd$0-1,060
-100.0%
0.00%
CMMB ExitChemomab Therapeutics Ltdadr$0-792
-100.0%
0.00%
MDWD ExitMediWound Ltd$0-2,024
-100.0%
0.00%
ENTX ExitEntera Bio Ltd$0-1,744
-100.0%
0.00%
DKNG ExitDraftKings Inccall$0-9,900
-100.0%
-0.00%
MKC ExitMcCormick & Co Inc/MDcall$0-1,815
-100.0%
-0.00%
ExitSomaLogic Inccall$0-300,000
-100.0%
-0.00%
ExitStraumann Holding AG$0-5,178
-100.0%
-0.04%
ExitSomaLogic Inc$0-10,390,335
-100.0%
-0.35%

The following EDGAR filing(s) were analyzed to create this report:

The EDGAR filing(s) were signed by:

  • Kellen Carter — Chief Compliance Officer

Compare quarterly holdings

Export ARK Investment Management's holdings

EDGAR filings